Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.78) by 2.56 percent. This is unchanged from the same period last year.
Mid-Afternoon Market Update: Crude Oil Down 5%; Celsion Shares Plummet
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 150 points on Wednesday.
